SCIENTIFIC MILESTONES

The creation of a Gene Bank for the prevention of Alzheimer’s for the population at risk.

The patenting of the world’s first Genetic Kit for molecular diagnosis of Alzheimer’s disease.

EuroEspes’ most important contribution during these last years has been the accomplishment of the first pharmacogenomic studies on Alzheimer’s disease.

EuroEspes has been at the forefront during the last twelve years with over 1.500 scientific contributions on the etiopathogeny and treatment of degenerative diseases of the Central Nervous System. This makes EuroEspes one of the most productive scientific groups in the European Union.

THERAPEUTIC MILESTONES

The launching of a highly precise Diagnostic Protocol with over 95% reliability for diseases specific to the Central Nervous System, which has been exported to other countries.
The development of the first Multifactorial Treatment, with superior results to those obtained with any other monotherapy for Alzheimer’s disease, and at a lower cost.
Being at the forefront of the development of first choice drugs for the treatment of Alzheimer’s disease during the last twelve years.

Being a pioneering organization in dealing with Cranioencephalic Traumatisms.

EuroEspes is one of the groups in Spain which has contributed most to innovation in the Pharmacological field for disorders of the Central Nervous System.

SOCIAL MILESTONES

The implementation at EuroEspes of an integral medicine at preventive, diagnostic, treatment and rehabilitative levels.

The organization of EuroEspes´ Day Center as a model of integral treatment at both pharmacological and psycological levels, related to psycho-sensorial stimulation and memory and creativity workshops.

EuroEspes’ Hospitalization Unit is monographic, and integrates medical treatment, specialized pharmacological treatment and neuro-rehabilitation, in order to improve the integral care for the patient, reduce the duration of the stay and help the patient’s readjustment to his surroundings.